Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Acute Decompensated Heart Failure; Renal Dysfunction

In brief

The purpose of this study is to determine the efficacy and safety of IV SLV320 in acute heart failure patients with renal dysfunction.

Key facts

Study ID
NCT00744341
Run by
Solvay Pharmaceuticals
People needed
46
Starts
2009-02-01
Expected to finish
2010-01-01
Last updated by the study team
2010-09-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.